Not Signed In -
Esophageal Cancer |
|
|
To meet Wikipedia's quality standards, this article or section may require cleanup. Please discuss this issue on the talk page, or replace this tag with a more specific message. Editing help is available. This article has been tagged since July. Esophageal cancer is malignancy of the esophagus. There are various subtypes. Esophageal tumors usually lead to dysphagia (difficulty swallowing), pain and other symptoms, and are diagnosed with biopsy. Small and localized tumors are treated with su ...
Wikipedia - [full article]
Esophageal Cancer Clinical Trials
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002711 - Active, not recruiting
stage III esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; ...
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00021320 - Active, not recruiting
stage 0 esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; ...
- Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
ClinicalTrials.gov Identifier: NCT00060268 - Active, not recruiting
recurrent esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer
- Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00006472 - Active, not recruiting
stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
- Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003118 - Active, not recruiting
stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
- Selective Dose Escalation for Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00139633 - Active, not recruiting
Esophageal Cancer
- PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00016900 - Active, not recruiting
stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; ...
- Esophageal Cancer Risk Registry
ClinicalTrials.gov Identifier: NCT00260585 - Recruiting
Esophageal Cancer; Gastroesophageal Reflux Disease; Esophageal Diseases; Hiatal Hernia; Esophageal Achalasia
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00093652 - Active, not recruiting
Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- Pre-Operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00160875 - Active, not recruiting
Esophageal Cancer
- Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003321 - Active, not recruiting
stage III esophageal cancer; stage IV esophageal cancer; recurrent esophageal cancer; stage I esophageal cancer; Quality of Life; ...
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00075738 - Active, not recruiting
stage IV esophageal cancer; recurrent esophageal cancer
- Selenium and Celecoxib, Alone or in Combination, in Preventing Cancer in Patients With Esophageal Dysplasia
ClinicalTrials.gov Identifier: NCT00005885 - Active, not recruiting
prevention of esophageal cancer; Esophageal Cancer
- Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002884 - Active, not recruiting
childhood gastrointestinal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
- Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00068380 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; stage IV esophageal cancer; stage III esophageal cancer; ...
- Cetuximab in Treating Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00096031 - Active, not recruiting
Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage IV esophageal cancer
- Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00030862 - Active, not recruiting
stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; squamous cell carcinoma of the esophagus; ...
- Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00368329 - Recruiting
Esophageal Cancer; Esophageal Diseases; Carcinoma, Squamous Cell; Adenocarcinoma; Cancer of Digestive System
- Study of TNFerade™ gene therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00051480 - Active, not recruiting
Esophageal Cancer
- Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00063986 - Recruiting
stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00040859 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Combination Chemotherapy and Interferon alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00004897 - Active, not recruiting
squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00107341 - Active, not recruiting
Adenocarcinoma of the Esophagus; stage IV esophageal cancer; recurrent esophageal cancer
- Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Genetic and Environmental Risk Factors for Esophageal Cancer in Patients With Esophageal Cancer and in Healthy Participants in Northern Iran
ClinicalTrials.gov Identifier: NCT00544843 - Recruiting
Esophageal Cancer; Healthy, no Evidence of Disease
- Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer.
ClinicalTrials.gov Identifier: NCT00153881 - Recruiting
Esophageal Neoplasm; Gastro-esophageal Neoplasm; Carcinoma of the Esophagus; Esophageal Cancer
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00002935 - Active, not recruiting
stage 0 esophageal cancer
- Cisptain, CPT-11 and Celecoxib with Radiation Therapy and Surgery for Operable Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00137852 - Active, not recruiting
Resectable Esophageal Cancer
- Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00005876 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Avastin and Taxotere for Esophagogastric Cancer
ClinicalTrials.gov Identifier: NCT00137813 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
ClinicalTrials.gov Identifier: NCT00010270 - Active, not recruiting
Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer
- 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00077545 - Active, not recruiting
recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus
- Radiotherapy, Combination Chemotherapy, and Gefitinib Before and After Surgery in Treating Patients With Advanced Esophageal or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00258323 - Active, not recruiting
Esophageal Cancer
- Combination Chemotherapy in Treating Patients With Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00041262 - Recruiting
stage II esophageal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus
- Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00066716 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
- Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00033657 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
ClinicalTrials.gov Identifier: NCT00201747 - Active, not recruiting
Esophageal Cancer; Esophagus Cancer; Cancer of Stomach; Stomach Cancer
- Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003087 - Active, not recruiting
stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II esophageal cancer; squamous cell carcinoma of the esophagus
- Irinotecan in Treating Patients With Esophageal or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
- Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00047112 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer
- Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00072033 - Active, not recruiting
stage II esophageal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus
- Combination Chemotherapy Combined with Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00008047 - Active, not recruiting
stage II esophageal cancer; stage III esophageal cancer
- Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002883 - Active, not recruiting
stage I gastric cancer; stage II gastric cancer; stage I esophageal cancer; stage II esophageal cancer; adenocarcinoma of the stomach; ...
- Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00052910 - Recruiting
Esophageal Cancer; Gastric Cancer
- Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00416858 - Active, not recruiting
Esophageal Cancer
- Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
ClinicalTrials.gov Identifier: NCT00558415 - Recruiting
Esophageal Cancer; Gastric Cancer
- Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00268437 - Active, not recruiting
Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma of the Esophagus; Stage III Esophageal Cancer; Stage II Esophageal Cancer
- Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children
ClinicalTrials.gov Identifier: NCT00551824 - Recruiting
Esophageal Stricture; Caustic Esophageal Stricture; Peptic Esophageal Stricture; Post-Surgical Esophageal Stricture
- Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00316862 - Recruiting
Esophageal Cancer
- Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00069953 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage II esophageal cancer; stage III esophageal cancer
- Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003487 - Recruiting
stage IV esophageal cancer; recurrent esophageal cancer; Adenocarcinoma of the Esophagus
- Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002897 - Active, not recruiting
squamous cell carcinoma of the esophagus; stage III esophageal cancer; stage II esophageal cancer
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00281788 - Recruiting
Esophageal Cancer
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00381706 - Recruiting
Esophageal Cancer
- Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00394433 - Recruiting
Esophageal Cancer; Stomach Cancer
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
ClinicalTrials.gov Identifier: NCT00084617 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00403468 - Recruiting
Esophageal Cancer; Gastric Cancer
- Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006081 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage IV gastric cancer; ...
- Gene Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
- Green Tea Extract in Preventing Esophageal Cancer in Patients With Barrett''s Esophagus
ClinicalTrials.gov Identifier: NCT00233935 - Recruiting
Esophageal Cancer; Precancerous Condition
- Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00520091 - Active, not recruiting
Esophageal Cancer
- BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00017043 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00003237 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage II esophageal cancer; ...
- Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003326 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; squamous cell carcinoma of the esophagus
- Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
- A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients with Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00037089 - Active, not recruiting
Esophageal Neoplasm
- PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00002930 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage III esophageal cancer; stage II non-small cell lung cancer; ...
- Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00100945 - Active, not recruiting
Adenocarcinoma of the Esophagus; stage II esophageal cancer
- Positron Emission Tomography in Determining Stage of Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00004867 - Completed
stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- Low-Dose CDGP/5-FU Combined With Radiation for Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00197444 - Recruiting
Esophageal Cancer; Squamous Cell Carcinoma
- Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia
ClinicalTrials.gov Identifier: NCT00357682 - Recruiting
Esophageal Cancer; Precancerous/Nonmalignant Condition
- Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
ClinicalTrials.gov Identifier: NCT00474903 - Recruiting
Esophageal Cancer; Precancerous/Nonmalignant Condition
- Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00544362 - Recruiting
Esophageal Cancer
- FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
ClinicalTrials.gov Identifier: NCT00098644 - Recruiting
Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
- Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00238147 - Recruiting
Esophageal Cancer
- Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00238407 - Recruiting
Esophageal Cancer
- Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00344552 - Recruiting
Esophageal Cancer
- Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00354679 - Recruiting
Esophageal Cancer
- Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001
ClinicalTrials.gov Identifier: NCT00522795 - Recruiting
Esophageal Cancer
- Phase I/II Study of TPF as First-Line Chemotherapy in Patients With Metastatic Esophageal Cancer.
ClinicalTrials.gov Identifier: NCT00209690 - Recruiting
Esophageal Cancer
- Weekly Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal Carcinoma
ClinicalTrials.gov Identifier: NCT00256269 - Recruiting
Esophageal Cancer; GE Junction Cancer
- Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-Treated Pts With Metastatic Esophageal Cancer.
ClinicalTrials.gov Identifier: NCT00209716 - Recruiting
Esophageal Cancer
- Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00445861 - Recruiting
Esophageal Cancer
- Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00268346 - Recruiting
Esophageal Cancer
- Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00393068 - Recruiting
Esophageal Cancer
- Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00004879 - Active, not recruiting
Colorectal Cancer; Esophageal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; Prostate Cancer
- Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00020761 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- FOLFOX-Cetuximab-Radiotherapy for the Treatment of Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00578201 - Recruiting
Stage III Esophageal Cancer
- BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00439608 - Active, not recruiting
Esophageal; Gastroesophageal; Gastric Cancer
- Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00372450 - Recruiting
Esophageal Cancer; Gastrointestinal Complications
- Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00290719 - Recruiting
Esophageal Cancer
- Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00400114 - Recruiting
Esophageal Cancer
- Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00453323 - Recruiting
Esophageal Cancer
- Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00561275 - Recruiting
Esophageal Cancer
- A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00383266 - Recruiting
Esophageal Neoplasms
- Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases
ClinicalTrials.gov Identifier: NCT00041158 - Recruiting
Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
Resources
- American Cancer Society
- Barrett's Esophagus (National Institute of Diabetes and Digestive and Kidney Diseases)
email this page
print this page
bookmark this page
feedback on this page
